pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
OM-301
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Oncolyze Inc
OMEGAVEN
OMEGAVEN (FISH OIL)
no indication
FRESENIUS KABI USA
OMIDRIA
OMIDRIA (PHENYLEPHRINE AND KETOROLAC)
no indication
RAYNER SURGICAL
Phase 2
OMO-1
Solid Tumor
← prev
page 117 of 231
next →
131
Pain
89
Neurology
1
DeuterOncology NV
Phase 1
OMS-527
Substance (Drug) Abuse
$OMER
OMEROS CORP
Phase 2
ONC-841
Colorectal Cancer
OncoC4 Inc
Phase 2
ONO-2020
Alzheimer's Disease
Ono Pharmaceutical Co Ltd
Phase 2
ONO-2808
Multiple System Atrophy (Multi-System Degeneration)
Ono Pharmaceutical Co Ltd
Phase 1
ONO-2910
Diabetic Neuropathy
Ono Pharmaceutical Co Ltd
Phase 1
OP-3136
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$OLMA
Olema Pharmaceuticals, Inc.
Preclinical
OPB-171775
Gastrointestinal Stromal Tumor (GIST)
$BDRX
Biodexa Pharmaceuticals Plc
Phase 2
OPC-1
Acute Spinal Cord Injury
$LCTX
Lineage Cell Therapeutics, Inc.
Phase 1
OPC-214870
Epilepsy
Otsuka Pharmaceutical Co Ltd
Phase 2
OPCT-001
Retinal Degeneration
BlueRock Therapeutics LP
Phase 2
OPF-310
Type 1 Diabetes (Juvenile Diabetes)
Otsuka Pharmaceutical Co Ltd
Phase 2
OPGx-BEST1
Macular Degeneration
$IRD
Opus Genetics, Inc.
Preclinical
OPGx-CNGB1
Retinitis Pigmentosa (Retinitis)
$IRD
Opus Genetics, Inc.
Phase 3
OPGx-LCA5
Leber Congenital Amaurosis (LCA)
$IRD
Opus Genetics, Inc.
Preclinical
OPGx-RDH12
Leber Congenital Amaurosis (LCA)
$IRD
Opus Genetics, Inc.
Preclinical
OPGx-RHO
Retinitis Pigmentosa (Retinitis)
$IRD
Opus Genetics, Inc.
Preclinical
OPK-88006
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
$OPK
OPKO HEALTH, INC.
Phase 1
OPL-009
Hypertension
Overseas Pharmaceuticals Ltd
Phase 3
OPL-015
Pain
Overseas Pharmaceuticals Ltd
Phase 1
OPN-6602
Refractory Multiple Myeloma
Opna Bio SA
Preclinical
OPTF-01
Glioblastoma Multiforme (GBM)
Optieum Biotechnologies Inc
OPTIONELLE
OPTIONELLE (LEVONORGESTREL TABLET, 1.5 MG)
no indication
NAARI PTE
OPTIRAY 320
OPTIRAY 320 (IOVERSOL)
no indication
LIEBEL-FLARSHEIM
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES (HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN)
no indication
GE HEALTHCARE
Preclinical
OQL-036
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome)
OnQuality Pharmaceuticals LLC
Preclinical
OQY-8811
Multiple Myeloma (Kahler Disease)
Oqory Inc
